Nuveen Asset Management LLC lowered its holdings in shares of Constellium SE (NYSE:CSTM - Free Report) by 5.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,851,001 shares of the industrial products company's stock after selling 111,479 shares during the period. Nuveen Asset Management LLC owned approximately 1.26% of Constellium worth $19,010,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Constellium by 26.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 19,828,738 shares of the industrial products company's stock worth $203,642,000 after purchasing an additional 4,181,823 shares in the last quarter. Nut Tree Capital Management LP lifted its holdings in shares of Constellium by 52.8% in the 4th quarter. Nut Tree Capital Management LP now owns 5,500,000 shares of the industrial products company's stock worth $56,485,000 after purchasing an additional 1,900,000 shares in the last quarter. D. E. Shaw & Co. Inc. lifted its holdings in shares of Constellium by 112.2% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 2,426,033 shares of the industrial products company's stock worth $24,915,000 after purchasing an additional 1,282,587 shares in the last quarter. Thrivent Financial for Lutherans lifted its holdings in shares of Constellium by 242.7% in the 4th quarter. Thrivent Financial for Lutherans now owns 1,522,400 shares of the industrial products company's stock worth $15,636,000 after purchasing an additional 1,078,196 shares in the last quarter. Finally, Bridgeway Capital Management LLC bought a new position in shares of Constellium in the 4th quarter worth $8,615,000. Institutional investors and hedge funds own 92.59% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Deutsche Bank Aktiengesellschaft upgraded Constellium from a "hold" rating to a "buy" rating and set a $15.00 target price on the stock in a report on Tuesday, February 25th.
Get Our Latest Analysis on CSTM
Constellium Stock Up 5.2%
Shares of CSTM stock traded up $0.61 during trading hours on Tuesday, reaching $12.29. The company had a trading volume of 1,406,983 shares, compared to its average volume of 1,448,577. Constellium SE has a 12 month low of $7.33 and a 12 month high of $22.00. The company has a debt-to-equity ratio of 1.93, a current ratio of 1.28 and a quick ratio of 0.52. The business has a fifty day simple moving average of $10.17 and a 200-day simple moving average of $10.64. The company has a market cap of $1.76 billion, a price-to-earnings ratio of 38.41 and a beta of 1.65.
Constellium (NYSE:CSTM - Get Free Report) last posted its earnings results on Wednesday, April 30th. The industrial products company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.07 by $0.19. The company had revenue of $1.98 billion for the quarter, compared to analyst estimates of $1.88 billion. Constellium had a return on equity of 4.83% and a net margin of 0.67%. The company's revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter last year, the company earned $0.11 earnings per share. On average, research analysts expect that Constellium SE will post 1.1 earnings per share for the current fiscal year.
Constellium Profile
(
Free Report)
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
Read More

Before you consider Constellium, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Constellium wasn't on the list.
While Constellium currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.